Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 5:00 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 834,449 3.8% | -204,786 (-19.71%) | View |
| 2021-02-12 3:18 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management LLC | 1,865,334 8.4% | 793,585 (+74.05%) | View |
| 2021-02-12 2:42 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | DIMENSIONAL FUND ADVISORS LP | 790,169 3.6% | 59,931 (+8.21%) | View |
| 2021-02-11 4:57 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | INTEGRATED CORE STRATEGIES (US) LLC | 683,930 3.1% | -33,435 (-4.66%) | View |
| 2021-02-10 3:04 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | BlackRock Inc. BLK | 1,352,532 4.4% | 5,137 (+0.38%) | View |
| 2021-02-10 10:39 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | VANGUARD GROUP INC | 982,403 4.45% | 379,106 (+62.84%) | View |
| 2021-02-04 5:28 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Mangrove Partners Master Fund Ltd. | 0 0% | -682,625 (Position Closed) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | BlackRock Inc. BLK | 1,347,395 6.1% | 1,071,316 (+388.05%) | View |
| 2020-08-06 11:13 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 1,114,604 6.39% | 878,853 (+372.79%) | View |
| 2020-08-06 11:13 am Unchanged | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 235,751 1.07% | 0 (Unchanged) | View |
| 2020-08-05 4:09 pm Unchanged | 13G | CATALYST BIOSCIENCES INC N CBIO | Stonepine Capital Management LLC | 1,039,235 6% | 0 (Unchanged) | View |
| 2020-08-05 09:23 am Unchanged | 13D | CATALYST BIOSCIENCES INC CBIO | 22NW LP | 735,841 34% | 0 (Unchanged) | View |
| 2020-02-12 3:53 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management LLC | 1,071,749 8.9% | 216,506 (+25.32%) | View |
| 2020-02-12 10:43 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | DIMENSIONAL FUND ADVISORS LP | 730,238 6.07% | 730,238 (New Position) | View |
| 2020-02-11 4:44 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | VANGUARD GROUP INC | 603,297 5.01% | 603,297 (New Position) | View |
| 2020-02-07 5:12 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Mangrove Partners Master Fund Ltd. | 682,625 5.67% | 83,106 (+13.86%) | View |
| 2020-01-17 4:52 pm Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | INTEGRATED CORE STRATEGIES (US) LLC | 717,365 6% | 11,831 (+1.68%) | View |
| 2020-01-17 12:40 pm Unchanged | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 398,838 3.3% | 0 (Unchanged) | View |
| 2019-12-30 5:34 pm Purchase | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 398,838 3.3% | 26,300 (+7.06%) | View |
| 2019-07-24 4:08 pm Purchase | 13D | CATALYST BIOSCIENCES INC CBIO | 22NW LP | 735,841 6.1% | 735,841 (New Position) | View |